• CmOGD2-Dependent Ferroptosis in Citrus Canker Resistance

  2026-08-04

  This study uncovers how the 2-oxoglutarate-dependent dioxygenase CmOGD2 in Citron C-05 orchestrates iron uptake and reactive oxygen species (ROS) accumulation, enabling robust resistance to citrus canker via ferroptosis. The work reveals an intricate feedback loop involving CmOGD2, CmENO2, and CmZAT10.1, with pathogen effectors modulating this circuit—offering novel mechanistic insight into plant defense and redox regulation.

• QNZ (EVP4593) in Translational NF-κB Pathway Modulation Work

  2026-08-04

  QNZ (EVP4593) stands out for nanomolar-precision NF-κB pathway inhibition in inflammation and neurodegenerative disease models. This guide details validated experimental workflows, practical troubleshooting, and evidence-based protocol enhancements for maximizing data quality with this anti-inflammatory compound.

• CAY10499: Lipase Inhibition as a Precision Tool for Macropha

  2026-08-03

  Discover how CAY10499, a potent inhibitor of human hormone sensitive lipase, enables unparalleled precision in dissecting the lipid-driven mechanisms that shape macrophage polarization and immunosuppressive activity in cancer. This article uniquely bridges molecular action with experimental strategy for translational immunometabolic studies.

• PP 3 as a Precision Tool for Dissecting Src Kinase Signaling

  2026-08-03

  Explore how 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) advances research use only chemical controls in Src kinase signaling pathway research. This article unveils assay design implications from recent vascular biology findings and provides advanced guidance for maximizing specificity in protein tyrosine kinase inhibition studies.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-08-02

  This study establishes a novel gastric cancer assembloid model, integrating tumor organoids with matched stromal cell subpopulations to better mimic the tumor microenvironment. The approach uncovers how stromal components modulate biomarker expression and drug sensitivity, offering a more physiologically relevant system for preclinical drug discovery and resistance analysis.

• Magnetic Stimulation Downregulates GABRE to Reverse SCZ Beha

  2026-08-01

  This study demonstrates that targeted combined magnetic stimulation system treatment (c-MSST) of the left prelimbic cortex selectively downregulates the GABAA receptor epsilon subunit (GABRE), reversing schizophrenia-like behaviors and synaptic deficits in mouse models. These findings identify GABRE as a mechanistic node for non-pharmacological intervention and provide a foundation for refining neuromodulation strategies relevant to schizophrenia research.

• Podophyllotoxin in Multidrug Resistance: Mechanistic Advance

  2026-07-31

  Explore how Podophyllotoxin, a potent cell cycle arrest agent, is redefining anticancer drug research by targeting multidrug-resistant cancer pathways. This in-depth review bridges recent mechanistic breakthroughs with practical assay guidance.

• Dendritic Cell-Mediated Targeted Delivery of Amikacin to Gra

  2026-07-31

  The reference study demonstrates a novel approach for delivering amikacin directly into mycobacterial granulomas by harnessing dendritic cells as targeted carriers. This strategy may enhance local antibiotic efficacy while minimizing systemic toxicity, offering a promising adjunct in antibiotic resistance research, especially for hard-to-treat nontuberculous mycobacterial infections.

• n-Dodecyl-β-D-maltoside: Optimizing Membrane Protein Purific

  2026-07-30

  n-Dodecyl-β-D-maltoside empowers reliable solubilization and stabilization of even the most challenging membrane proteins, bridging the gap between bench-scale experiments and high-resolution structural studies. Drawing on cutting-edge protocols and troubleshooting insights, this article reveals how DDM transforms workflows for kinetic analysis, folding assays, and advanced cryo-EM applications.

• Brassinolide (24-Epibrassinolide): Mechanisms & Research Ben

  2026-07-30

  Brassinolide, a bioactive plant sterol, is a dual-domain reagent with validated roles in plant growth regulation and apoptosis induction in cancer research. It modulates root growth independently of light and induces cell cycle arrest in PC-3 prostate cancer cells. The A3265 product from APExBIO delivers high-purity brassinolide for reproducible results across plant and disease models.

• IR-820 (New Indocyanine Green): Precision Near-Infrared Imag

  2026-07-29

  IR-820 (New Indocyanine Green) unlocks deep-tissue imaging and quantification in preclinical models, excelling in both standalone and nanoparticle-integrated workflows. Its robust near-infrared fluorescence, rapid tissue uptake, and compatibility with advanced photothermal-immunotherapy platforms set it apart for translational research applications.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-07-29

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe is designed for precise, high-contrast plasma membrane labeling in live and fixed cells. It is ideal for applications such as neuronal tracing and cell migration assays, but is not suitable for water-based protocols or labeling intracellular organelles due to its lipophilic nature.

• Aprotinin (BPTI): Precision Fibrinolysis Inhibition in Resea

  2026-07-28

  Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) delivers reproducible, high-potency serine protease inhibition for workflows demanding reliable perioperative blood loss reduction and inflammation control. This guide translates recent mechanistic findings and comparative protocol insights into practical, bench-ready strategies for maximizing assay integrity.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-07-28

  MTT empowers researchers with a robust, quantifiable readout for in vitro cell viability and metabolic activity, driven by NADH-dependent reduction mechanisms. APExBIO’s high-purity MTT (SKU B7777) supports advanced workflows and troubleshooting strategies for reproducible, high-throughput biomedical research results.

• G-15: Selective GPR30 Antagonist for Estrogen Signaling Rese

  2026-07-27

  G-15 is a high-affinity, selective G protein-coupled estrogen receptor (GPR30) antagonist widely used in estrogen signaling research. It effectively blocks GPR30-mediated intracellular calcium mobilization and PI3K/Akt pathway activation without affecting classical estrogen receptors. This article details the biological rationale, mechanism, evidence, and workflow integration for G-15 in experimental systems.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page